Category: CBSA News

A Market Outlook for 2025 and Beyond CBRE is the world’s largest commercial real estate services and investment firm, providing services to both occupiers and investors in real estate, with a global p...

Last week, Colorado Bioscience Association (CBSA) Vice President and Counsel for Policy + Advocacy, Amy Goodman, joined state leaders as part of the Biotechnology Innovation Organization (BIO) Council...

Colorado’s legislature is considering two bills related to the federal 340B Drug Pricing Program and both bills are now advancing to the House after passing out of the Senate today.   Colora...

Inspiration, innovation, and thoughts on the future from top women scientists. At Fitzsimons Innovation Community, women in STEM isn’t just a buzz phrase. Many of the innovative companies on our campu...

Life Sciences Community,   Colorado’s legislature is considering two bills related to the federal 340B Drug Pricing Program and both bills are expected to be debated on the Senate floor as early...

BIO CEO John F. Crowley provided insights during a roundtable discussion with Rep. Diana DeGette, CBSA, ClinImmune, RheumaGen, and CU Anschutz at Fitzsimons Innovation Community in February. In a rece...

03/07/2025 Update & Thank You: State Support for Life Sciences Thank you! We’ve been hearing that many of you are contacting the JBC and Governor’s Office. We are so appreciative of your outreach...

For Immediate Release: March 5, 2025 Leaders from BioMed Realty, Fitzsimons Innovation Community, J.P. Morgan, and Umoja Biopharma Join CBSA Board Denver – Colorado BioScience Association (CBSA), whic...

Date: February 20, 2025 By: Fitzsimons Innovation Community Talking leadership and the future with Fitzsimons Innovation Community’s New President and CEO. Kelly Brough likes to get stuff done. Her fa...

Life Sciences Community: Funding for research-intensive industries is under threat at the federal and state level. This update outlines what we know right now and how Colorado BioScience Association c...